New York City—May 20, 2010
“The ISOC was founded to facilitate the exchange of ideas and innovative practices among the orthopedic community and to improve patient care, education and research on a global scale,” said Thomas P. Sculco, M.D., surgeon-in-chief at Hospital for Special Surgery and ISOC founder who presented at the meeting.
The symposium in Bologna built upon solutions presented at the past two meetings. “ISOC presents an extraordinary opportunity for 14 institutions considered a model of excellence in orthopedics in their respective markets to come together in the spirit of collaboration and share processes and procedures, retrospective and prospective data, and education and training programs with the primary focus of improving patient care and outcomes,” said Louis A. Shapiro, FACHE, president and chief executive officer of Hospital for Special Surgery.
Scientific and academic sessions at the ISOC meeting highlighted research and advanced clinical practice from each participating institution. Chief executive officers participated in a parallel discussion on the opportunities and administrative challenges of operating orthopedics programs at a time when demand for services is unprecedented, leading to record growth. Challenges discussed included maintaining high quality and service during periods of high growth, increasing efficiencies to meet capacity demands, and overcoming physical expansion constraints by identifying opportunities in other geographic areas. The group agreed to continue the dialogue throughout the year sharing best practices and performances.
At its last meeting in 2008, the ISOC produced a consensus paper on challenges facing orthopedic care and initiated four task forces: Education/Fellowship; Outcome/Clinical Studies/Registries; Implant Retrieval; and Information Exchange/Website.
The next meeting is scheduled for 2011 in Chile.
The ISOC objectives are to promote scientific, clinical and educational collaboration among participating institutions; to improve quality of patient care through sharing of clinical pathways and treatments; to collaborate on academic programs through the exchange of residents, fellows and faculty; and to share strategies on clinical pathways for patients and cost effective measures for economic success for major orthopedic programs.
ISOC membership has grown from 10 institutions in 2007 to 14 in 2010 at this year’s meeting, which ran from Apr. 29 to May 1. In addition to the hosting institution, this year’s attendees included Hospital for Special Surgery; Campbell Clinic, Germantown, Tenn.; Mayo Clinic, Rochester, Minn.; Clinica Alemana (Chile), Endo Klinik (Germany), Instituto Nacional De Rehabilitacion (Mexico), Istituto Ortopedico Galeazzi (Milan, Italy), Lund University Hospital (Sweden), Royal National Orthopaedic Hospital (United Kingdom), Schulthess Klinik (Switzerland), Sint Maartenskliniek (The Netherlands) and University Hospitals Leuven (Belgium).
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.